Deal to establish a dedicated, first-of-its-kind, U.S. final stage API manufacturing and supply plat

FLORHAM PARK, N.J. & SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Celularity Inc. (Nasdaq: CELU) (“Celularity

Celularity Inc. (Nasdaq: CELU) ("Celularity"), a longevity-focused regenerative and cellular

FLORHAM PARK, N.J., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”),

S&P 500 to open higher? Polymarket odds reach 70% as Wall Street digests September jobs, 24-year

Celularity highlights Fontaine Vitale's planned Q1 2027 opening in Bali, creating potential new reve

Celularity (NASDAQ:CELU) reported quarterly earnings of $0.02 per share. This is a 102.38 percent in

FLORHAM PARK, N.J., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”

Plan combines up to $25 million in new capital with restructuring of $3 million in existing debt to

Celularity closes $10 million financing in an up to $28 million recapitalization, advancing growth a

Will S&P 500 open higher? Polymarket odds hit 65% as Wall Street digests Fed independence debate

Gainers Quoin Pharmaceuticals (NASDAQ:QNRX) shares rose 24.6% to $6.42 during Friday's regular

Celularity (CELU) stock surged 131% following a $300M U.S. manufacturing collaboration with MuseCell

Gainers Celularity (NASDAQ:CELU) stock moved upwards by 134.0% to $2.06 during Thursday's regul

Collaboration is intended to expand U.S. manufacturing of Dezawa MuseCells® initially across qualifi

[url="]Celularity Inc.[/url] (Nasdaq: CELU) (“Celularity”), a longevity-focused regenerative and

The initial program is designed to establish manufacturing capability for MCI-authenticated DMC prep

FLORHAM PARK, N.J. & SINGAPORE--(BUSINESS WIRE)--Celularity Inc. and MuseCell Innovations announce U

Gainers Veeva Systems (NYSE:VEEV) shares increased by 8.7% to $266.15 during Wednesday's after-

Gainers Nuwellis (NASDAQ:NUWE) stock increased by 27.2% to $1.22 during Wednesday's pre-market

FLORHAM PARK, N.J., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”)

Gainers Vicore Pharma Holding (NASDAQ:VCRE) stock rose 149.8% to $42.47 during Monday's after-m

Gainers Innovative Eyewear (NASDAQ:LUCY) stock moved upwards by 95.4% to $1.49 during Monday's

 On June 29, 2026, Celularity Inc. (the "Company") entered into a Loan Agreement (the "L

FLORHAM PARK, N.J. and ORLANDO, Fla.

FLORHAM PARK, N.J., June 03, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) ("Celularity" o

FLORHAM PARK, N.J., June 03, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” o

- Celularity Inc. (NASDAQ:CELU) (the "Company"), a longevity-focused regenerative and cellul

FLORHAM PARK, N.J., May 29, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”),

Entry into a Material Definitive Agreement. As previously disclosed by Celularity Inc. (the "Com

Company advances focused strategy, strengthens balance sheet and positions business for long-term gr

Veteran Financial and M&A Leader Appointed to Integrate Acquisition of Celularity, Scale the Busines

Transaction expected to approximately triple NEXGEL's annual revenue to approximately $35 million an

FLORHAM PARK, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”)

Celularity Inc. (NASDAQ:CELU) (the "Company"), a longevity-focused regenerative and cellular

FLORHAM PARK, N.J., April 17, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”

Celularity (NASDAQ: CELU - Get Free Report) and KALA BIO (NASDAQ: KALA - Get Free Report) are both s

Transaction expected to approximately triple NEXGEL's annual revenue to about $35 million and is

FLORHAM PARK, N.J., March 12, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”

Celularity Inc. (Nasdaq: CELU) ("Celularity" or the "Company"), a regenerative and c

The transaction represents the most significant milestone in the company's history.

NexGel to acquire Celularity biomaterial products, a deal expected to triple revenue to $35 million

Celularity Inc. (NASDAQ:CELU) ("Celularity"), a longevity-focused regenerative and cellular

Celularity Inc. Up to 14,078,938 shares of Class A Common Stock Pursuant to this prospectus, the sel

On December 1, 2025, Celularity Inc., (the "Company") received a warning letter (the "Le

Celularity Inc. (NASDAQ:CELU) ("Celularity"), a regenerative and cellular medicine company a

Private Placement Transaction On October 24, 2025, Celularity Inc. (the "Company") entered i